OG视讯官网

News

Company News

Year

All

Please Select

LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%

View Details

2026 / 03 / 31
LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

View Details

2025 / 08 / 29
LifeTech Scientific Corporation Announced 2024 Annual Results：：：Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%

View Details

2025 / 03 / 28
LifeTech Scientific Corporation Announced 2023 Annual Results：：：International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development

View Details

2024 / 04 / 02
LifeTech Scientific Corporation Announced 2024 Interim Results：：：International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%

View Details

2024 / 08 / 30
LifeTech Scientific Corporation（1302.HK） Announces 2023 Interim Results

View Details

2023 / 08 / 30
LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022

View Details

2023 / 03 / 30
FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre? Plus LAA Closure System Obtained Medical Insurance Coverage in the US

View Details

2022 / 09 / 05
LifeTech Scientific Corporation（1302.HK）Announces 2022 Interim Results

View Details

2022 / 08 / 31
LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual Results

View Details

2022 / 03 / 30

14F, LifeTech Scientific Building, Keji 12th Road South, High-tech Industrial Park, Nanshan District, Shenzhen City, Guangdong Province, 518063, PRC

Tel：：：+86 755 86026250
Fax：：：+86 755 86026251

Last Updated December 2023

Legal Statement Privacy Policy

【网站地图】

OG视讯官网

News

LifeTech Scientific Corporation Announces 2025 Annual Results: Steady Revenue Growth with Adjusted Net Profit Increasing 24.9%

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

LifeTech Scientific Corporation Announced 2024 Annual Results：：：Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%

LifeTech Scientific Corporation Announced 2023 Annual Results：：：International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development

LifeTech Scientific Corporation Announced 2024 Interim Results：：：International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%

LifeTech Scientific Corporation（1302.HK） Announces 2023 Interim Results

LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022

FDA-approved Investigator-initiated Pre-market Clinical Trial of LAmbre? Plus LAA Closure System Obtained Medical Insurance Coverage in the US

LifeTech Scientific Corporation（1302.HK）Announces 2022 Interim Results

LifeTech Scientific Corporation（1302.HK） Announces 2021 Annual Results

LifeTech Scientific Corporation Announced 2024 Annual Results：：：Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%

LifeTech Scientific Corporation Announced 2023 Annual Results：：：International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development

LifeTech Scientific Corporation Announced 2024 Interim Results：：：International Business Increased by 30%, Net Profit Margin Attributable to Owners of the Company Reached 35.8%